IT1212085B - I singoli fattori 1, 2, 3, 4 e 5della teicomicina a2 puri ed il metodo per la loro produzione. - Google Patents

I singoli fattori 1, 2, 3, 4 e 5della teicomicina a2 puri ed il metodo per la loro produzione.

Info

Publication number
IT1212085B
IT1212085B IT8321432A IT2143283A IT1212085B IT 1212085 B IT1212085 B IT 1212085B IT 8321432 A IT8321432 A IT 8321432A IT 2143283 A IT2143283 A IT 2143283A IT 1212085 B IT1212085 B IT 1212085B
Authority
IT
Italy
Prior art keywords
theichomycin
pure
production
single factors
factors
Prior art date
Application number
IT8321432A
Other languages
English (en)
Other versions
IT8321432A0 (it
Inventor
Angelo Borghi
Rosa Pallanza
Lina Coronelli
Giovanni Cassani
Original Assignee
Milano A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milano A filed Critical Milano A
Publication of IT8321432A0 publication Critical patent/IT8321432A0/it
Application granted granted Critical
Publication of IT1212085B publication Critical patent/IT1212085B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT8321432A 1982-06-08 1983-06-02 I singoli fattori 1, 2, 3, 4 e 5della teicomicina a2 puri ed il metodo per la loro produzione. IT1212085B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (2)

Publication Number Publication Date
IT8321432A0 IT8321432A0 (it) 1983-06-02
IT1212085B true IT1212085B (it) 1989-11-08

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8321432A IT1212085B (it) 1982-06-08 1983-06-02 I singoli fattori 1, 2, 3, 4 e 5della teicomicina a2 puri ed il metodo per la loro produzione.

Country Status (32)

Country Link
US (1) US4542018A (it)
JP (5) JPS591423A (it)
KR (1) KR900008246B1 (it)
AU (1) AU560966B2 (it)
BE (1) BE896993A (it)
BG (1) BG60529B2 (it)
CA (1) CA1208204A (it)
CH (1) CH657139A5 (it)
DE (1) DE3320342A1 (it)
DK (1) DK159117C (it)
ES (2) ES8503689A1 (it)
FI (1) FI73697C (it)
FR (1) FR2528050B1 (it)
GB (1) GB2121401B (it)
GR (1) GR78267B (it)
HK (1) HK55887A (it)
HU (1) HU193538B (it)
IE (1) IE55025B1 (it)
IL (1) IL68819A0 (it)
IT (1) IT1212085B (it)
LU (1) LU84853A1 (it)
MY (1) MY8700002A (it)
NL (1) NL8301980A (it)
NO (1) NO159104C (it)
NZ (1) NZ204480A (it)
PH (1) PH19533A (it)
PT (1) PT76831B (it)
SE (1) SE459094B (it)
SG (1) SG70686G (it)
SU (1) SU1318170A3 (it)
UA (1) UA6025A1 (it)
ZA (1) ZA833607B (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
HUT63860A (en) * 1990-12-05 1993-10-28 Lepetit Spa Process for producing 39-decarboxy-38-(hydroxymethyl) derivatives of teikoplanin antibiotics
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
EP0912604B1 (en) 1996-04-23 2001-11-14 Biosearch Italia S.p.A. Improved chemical process for preparing amide derivatives of antibiotic A 40926
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
HUE041133T2 (hu) 2002-11-18 2019-05-28 Vicuron Pharmaceuticals Llc Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
IE831329L (en) 1983-12-08
ZA833607B (en) 1984-03-28
IT8321432A0 (it) 1983-06-02
KR900008246B1 (ko) 1990-11-06
FR2528050A1 (fr) 1983-12-09
JPH02288887A (ja) 1990-11-28
HU193538B (en) 1987-10-28
FR2528050B1 (fr) 1987-03-20
NO159104C (no) 1988-11-30
NZ204480A (en) 1986-04-11
ES522941A0 (es) 1985-04-01
ES8503689A1 (es) 1985-04-01
JPH0517237B2 (it) 1993-03-08
MY8700002A (en) 1987-12-31
SE8303211D0 (sv) 1983-06-07
PT76831B (en) 1986-04-09
FI831660A0 (fi) 1983-05-12
GR78267B (it) 1984-09-26
GB2121401B (en) 1985-09-18
JPH0224278B2 (it) 1990-05-29
DK245883D0 (da) 1983-05-31
GB2121401A (en) 1983-12-21
BE896993A (fr) 1983-12-07
DE3320342A1 (de) 1983-12-08
DK159117B (da) 1990-09-03
HK55887A (en) 1987-08-07
CA1208204A (en) 1986-07-22
SG70686G (en) 1987-07-03
FI73697C (fi) 1987-11-09
LU84853A1 (fr) 1984-03-07
JPH02291279A (ja) 1990-12-03
FI831660L (fi) 1983-12-09
JPH0415237B2 (it) 1992-03-17
JPH02291278A (ja) 1990-12-03
IL68819A0 (en) 1983-09-30
FI73697B (fi) 1987-07-31
CH657139A5 (fr) 1986-08-15
US4542018A (en) 1985-09-17
JPH0517236B2 (it) 1993-03-08
DE3320342C2 (it) 1991-07-11
NO831754L (no) 1983-12-09
PH19533A (en) 1986-05-20
ES8506748A1 (es) 1985-08-16
JPS591423A (ja) 1984-01-06
IE55025B1 (en) 1990-04-25
JPH0415238B2 (it) 1992-03-17
SE8303211L (sv) 1983-12-09
PT76831A (en) 1983-07-01
DK159117C (da) 1991-02-11
KR840005170A (ko) 1984-11-05
NO159104B (no) 1988-08-22
ES536770A0 (es) 1985-08-16
SU1318170A3 (ru) 1987-06-15
SE459094B (sv) 1989-06-05
NL8301980A (nl) 1984-01-02
JPH02288888A (ja) 1990-11-28
GB8315003D0 (en) 1983-07-06
BG60529B2 (bg) 1995-07-28
UA6025A1 (uk) 1994-12-29
AU1496883A (en) 1983-12-15
AU560966B2 (en) 1987-04-30
DK245883A (da) 1983-12-09

Similar Documents

Publication Publication Date Title
IT1212085B (it) I singoli fattori 1, 2, 3, 4 e 5della teicomicina a2 puri ed il metodo per la loro produzione.
IT8319420A0 (it) Soluzioni di insulina stabilizzate e metodi per la loro produzione.
ES516004A0 (es) "perfeccionamiento en la produccion de substratos nervados para electrodos".
IT8619713A0 (it) Benzimmidazol-derivati 5-sostituiti contenenti zolfo e procedimento per la loro produzione.
EP0202001A3 (en) Process for the production of 2,2,6,6,-tetraalkyl 4 piperidylamines
IT1214587B (it) Metodo per la produzione diprodotti cristallini puri.
IT8567924A1 (it) Sbozzi ottici e procedimento per la loro produzione.
PL266932A1 (en) The method of manufacture of new 1,4-benzodiasepine
ES538579A0 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
IT1147923B (it) Procedimento per la produzione di ditiazolil-2(2.2')-disolfuri
KR860700207A (ko) 밀납보리로부터 생성물을 회수하는 방법
IT1172398B (it) Procedimento per la produzione di 1,2-diclorcetano
IT8948551A0 (it) Procedimento per la produzione di analgesia in mammiferi.
DE3378536D1 (en) 1,3-dithianes, their production and use
IS2902A7 (is) Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis
IT8320259A0 (it) Procedimento di produzione dell'aspartame.
ES530213A0 (es) Un procedimiento para la produccion de una 1, 4-dihalogenobutano-2, 3-diona
IT1173751B (it) Farmaci contenenti muzolimin,loro impiego e procedimenti per la loro produzione
ES519108A0 (es) Procedimiento para la produccion de una 3,3-dialquil-o 3,3-dialquileno-indolina.
FI841640A (fi) Separation av 1,8-kineol.
OA08376A (en) 3,7-disubstituted-3-cephem compounds and processes for production of the same.
FR2583040B1 (fr) Procede pour la production de 2,6-naphtalenediol et de 2,6-diacetoxynaphtalene
IT1148404B (it) 2-fenil-2h-1,2,3-triazoli,procedimenti per la loro produzione e loro impiego
DE3564433D1 (en) Process for the production of 1,3,5-trithiane
ES272852Y (es) "aparato para la produccion de granizado".

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 90

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 90, 19920410; GRUPPO LEPETIT S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960506